INTERPACE BIOSCIENCES, INC. Annual Revenues in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Interpace Biosciences, Inc. quarterly/annual Revenues history and growth rate from 2013 to 2022.
  • Interpace Biosciences, Inc. Revenues for the quarter ending December 31, 2022 was $1K.
  • Interpace Biosciences, Inc. Revenues for the twelve months ending December 31, 2022 was $5.68M.
  • Interpace Biosciences, Inc. annual Revenues for 2022 was $5.68M, a 30.7% decline from 2021.
  • Interpace Biosciences, Inc. annual Revenues for 2021 was $8.2M.
  • Interpace Biosciences, Inc. annual Revenues for 2018 was $21.9M.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.68M -$2.52M -30.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $8.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2018 $21.9M Jan 1, 2018 Dec 31, 2018 10-K 2019-03-21
2014 $120M -$26.6M -18.2% Jan 1, 2014 Dec 31, 2014 10-K 2015-03-05
2013 $147M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.